Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023
[106 Pages Report] The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%.
Market Growth Drivers:
1. Increasing Worldwide Prevalence of Infectious Diseases
2. Rising Focus on Decentralized Diagnostics
3. Growing Demand for Clia-Waived Molecular POC Tests
Opportunities in Market:
1. Growing R&D Activities in Molecular Diagnostic Testing
2. Increasing Penetration of POC Molecular Diagnostic Tests in China, India, and Brazil
Objectives of Study:
1. To define, describe, and segment the global Point of care molecular diagnostics market by product & service, technology, application, end user, and region
2. To provide detailed information about factors influencing market growth (drivers, restraints, and opportunities)
3. To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global POC molecular diagnostics market
4. To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
5. To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=143524127
Market Segmentation:
Applications:
Based on the applications, the market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, Herpes Simplex Virus, Ebola, Zika virus). The respiratory application segment is expected account for the largest share of the global POC molecular diagnostics market in 2018.
Products and Services:
The POC molecular diagnostics market is broadly segmented into instruments, assays & kits, and services & software based on the basis of product & service. Assays & kits segment is expected to account for the largest share of the global POC molecular diagnostics market and expected to register the highest CAGR during the forecast period. POC molecular diagnostic assays and kits are specially designed for points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts.
Geographic Growth:
Detailed analysis of POC molecular diagnostics market in European countries such as the UK, Germany, France, Italy, Spain, and others.
Detailed analysis of POC molecular diagnostics market in Asia Pacific countries such as China, Japan, India, and others.
North America is expected to account for the largest share of the global POC molecular diagnostics market. Growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives are the major factors driving the growth of this market in North America. However, Asia Pacific is expected to grow at highest CAGR during forecast period.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127
Key Players:
The key players in the global POC molecular diagnostics market are Abbott Laboratories (US), Biomerieux (France), Danaher (US) Roche diagnostics (Switzerland), Meridian biosciences (US), Quidel (US). These players focus on organic strategies such as product launches & approvals, to sustain their growth in the POC molecular diagnostics market.
Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
What the Market Looks Like?
The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%.
Therapeutic Application: The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period.
Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA.
In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion.
The method of identifying the genetic code of an organism into the DNA sequence is known as DNA sequencing.
It refers to any approach or procedure used to determine how the four bases in DNA are arranged in a DNA sequence.
Chemical ionisation and connection of DNA sequencing equipment and services to an alkaline base are used in other approaches.The advantages of DNA sequencing equipment and services over alternative technologies are numerous.
For starters, precise measurements can be made without changing the DNA structure.
It also identifies regions of DNA sequence variation.
This allows DNA sequencing equipment and services to be used in a variety of fields of DNA biology, including inherited disorders and ageing.
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.
Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).
To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this link The USD 1.1 billion (by 2030) financial opportunity within the handheld ultrasound imaging devices market has been analyzed across the following segments:Application AreaCardiac ScanningEmergency MedicinesGynecological / Obstetrics ScanningMusculoskeletal ScanningPulmonary ScanningUrological ScanningVascular SurgeryOther Application Areas Type of Transducer ArrayCurvedEndocavityLinearPhasedOther Scanners Type of SoftwareSmartphone ApplicationsCustomized Software End-UsersAmbulatory Surgical CentersDiagnostic Imaging CentersHospitalsMaternity ClinicsSpecialty ClinicsOther End-Users Key Geographical Regions North AmericaEuropeAsia-Pacific and the Rest of the World The Global Handheld Ultrasound Imaging Devices Market, 2020-2030, report features the following companies, which we identified to be key players in this domain: Aidmax MedicalBeijing Konted Medical TechnologyBiim UltrasoundBreastITButterfly NetworkCJ MedicalClarius Mobile HealthEchoNousFujifilmGE HealthcareGuangzhou Top Medical EquipmentHealcerionInterson Medical InstrumentsPhilipsSomax SystemsVINNOWuHan Youkey Bio-Medical ElectronicsYor Labs Table of Contents Preface 2.
Executive Summary Introduction Market Landscape Company Profiles Brand Positioning Analysis of Key Players Partnerships and Collaborations Cost Saving Analysis Demand Analysis Market Forecast End-User Specific Opportunity Analysis Case Study: Impact of Coronavirus Outbreak Conclusion Executive Insights Appendix 1: Tabulated Data Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]
According to the new market research report “Single-Use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical Companies, CMOs and CROs) – Global Forecast to 2024” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The single-use assemblies market is projected to reach USD 1,825 million in 2024 from USD 805 million in 2019, at CAGR of 16.5% during the forecast periodGrowth Boosting Factors:– Rapid Implementation and Low Risk of CROs s-Contamination– Increasing Biopharmaceutical R– Emerging CountriesBrowse 102 Market Data Tables and 33 Figures spread through 148 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549Leading Key Players in the Worldwide Industry:The major companies in the single-use assemblies market include Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher (US), Merck Millipore (Germany)), and GE Healthcare (US).Sartorius Stedim Biotech (France) is the most significant player in the global market.
The company has an expansive range of single-use assemblies products.
The growth of revenue strongly backed up by demand from the Americas and APAC countries and efforts of the company to meet the differentiated needs of consumers from emerging Asian markets.
The company launched two single-use filter assemblies products in the past three years, including such as Sartocon Self-contained Filter Loop Assembly and Sartocon Slice Self-contained Bag Loop Assembly.
The company also focuses on inorganic growth strategies such as partnership, collaboration, and acquisitions to strengthen its position in the market.Geographical Regions Mapped in Report:The single-use assemblies market is divided into four major regions-Europe, North America, Asia Pacific, and the Rest of the World (RoW).
In 2018, North America accounted for the largest share of the global market, closely followed by Europe.
